Svoronos Dawn

CIK 00015745797 companiesBURNABY

SEC Profile

Transactions

Companies

Filings

CIK

0001574579

Recent Transactions

50 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2026-06-03+10,507→ 10,507 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-06-03+1,593→ 1,593 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-06-01+2,645→ 27,645 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2026-06-01$53.41/sh−1,416→ 26,229 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2026-06-01−2,645→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,000→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−10,450→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−10,520→ 0 total
Disposition to Issuer
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-12-09−4,500→ 0 total
Disposition from Tender
Adverum Biotechnologies, Inc.
Common Stock
2025-12-09−5,000→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2025-06-17+10,450→ 10,450 total
Award
Xenon Pharmaceuticals Inc.$XENE
Restricted Share Units
2025-06-05+2,645→ 2,645 total
Award
Xenon Pharmaceuticals Inc.$XENE
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−155,450→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Common Stock
2025-05-21−15,000→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−92,158→ 0 total
Disposition to Issuer
ACELYRIN, Inc.
Director Stock Option (right to buy)
2025-05-21−23,243→ 0 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2024-06-17+10,520→ 10,520 total
Award
ACELYRIN, Inc.
Director Stock Option (right to buy)
2024-06-07+92,158→ 92,158 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2024-06-05+15,542→ 15,542 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2023-08-24$38.70/sh−25,000→ 25,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2023-06-09+40,000→ 40,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09−155,450→ 0 total
Purchase
ACELYRIN, Inc.
Common Stock
2023-05-09$18.00/sh+15,000→ 15,000 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09+155,450→ 155,450 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09+23,243→ 23,243 total
Other
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-09−23,243→ 0 total
Award
ACELYRIN, Inc.
Director Stock Option (right to buy)
2023-05-04+23,243→ 23,243 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−7,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−30,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−5,376→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,247→ 0 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2022-06-28+18,000→ 18,000 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2022-06-21$27.24/sh−1,908→ 5,376 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-14−3,600→ 0 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-14+3,600→ 3,600 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-06-14+3,600→ 7,284 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-14+5,600→ 5,600 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2022-06-10+40,000→ 40,000 total
Sale
PTC THERAPEUTICS, INC.$PTCT
Common Stock
2022-06-09$27.20/sh−738→ 29,017 total
Purchase
Adverum Biotechnologies, Inc.
Common Stock
2022-05-16$0.85/sh+30,000→ 50,000 total
Award
PTC THERAPEUTICS, INC.$PTCT
Stock Option (Right To Buy)
2022-01-07+12,000→ 12,000 total
Award
PTC THERAPEUTICS, INC.$PTCT
Common Stock
2022-01-07+3,200→ 29,755 total
Sale
PTC THERAPEUTICS, INC.$PTCT
Common Stock
2022-01-07$38.52/sh−510→ 26,555 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2021-06-18$36.54/sh−1,609→ 3,684 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-17−3,037→ 0 total

Companies

Recent Filings

Address

3650 GILMORE WAY

BURNABY, V5G 4W8

View on SEC.gov